Blood grouping service for Gloucestershire Hospitals goes to QuidelOrtho
- Gloucestershire Hospitals NHS Foundation Trust
- South West
- Call-off from a framework agreement
- 9 October 2026 to 8 September 2031
Gloucestershire Hospitals NHS Foundation Trust is buying its blood grouping analysers, reagents and upkeep from QuidelOrtho as one managed service.
The analysers group blood, screen it for antibodies and cross-match it for transfusion. The trust estimated 50,000 blood groups, 50,000 antibody screens and 1,500 cross-matches a year. Automated testing with electronic transfer of results is required for Electronic Issue (EI) of blood. EI lets compatible blood go out quickly and cuts waste. QuidelOrtho also maintains the analysers, supplies quality control materials and trains users.
The trust ordered the service through NHSSC's Laboratory Diagnostics, Point of Care Testing & Pathology Managed Services framework, using its direct award route. The £1,091,844 contract was awarded in September 2026 and runs for five years, to September 2031.
Contract ends September 2031
- What
- Blood transfusion laboratory systems
- Supplier
- QuidelOrtho
- Value
- £1.09m
- How it was bought
- Call-off from a framework agreement
- Dates and next
- Oct 2026 to Sep 2031